NCT06202222Recruiting
Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection
Interest of Intensive Postoperative Rehabilitation Following Minimally Invasive Lung Resection: A Randomized Controlled Study
Source: ClinicalTrials.gov · Last updated 10 Sept 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
For patients diagnosed with non-small cell lung cancer (NSCLC), lung resection surgery remains the gold standard for curative treatment. This scheduled operation is associated with significant morbidity, particularly in individuals with impaired cardio-respiratory function. Therefore, patient optimization is paramount. The process begins prior to surgery with preoperative rehabilitation, commonly referred to as "prehabilitation," serving as the foundation for various Enhanced Recovery After Surgery programs. The training methods employed in these programs bear similarity to rehabilitation programs designed for patients with chronic obstructive pulmonary disease (COPD). Postoperatively, patients undergoing thoracic surgery partake in daily physiotherapy sessions, aiming to optimize the postoperative period, minimize the respiratory impact of surgery, and reduce the length of hospital stay. However, this treatment is not currently standardized and primarily involves early mobilization, including walking, and respiratory physiotherapy. Our focus is on the intensity and methods of this postoperative rehabilitation. There is limited literature on effective early rehabilitation in the immediate postoperative period, and existing studies suggest no adverse events associated with postoperative training. Therefore, our objective is to assess whether combining endurance training with standard physiotherapy (walking and respiratory physiotherapy) enhances the functional capacity of individuals undergoing lung surgery.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 184 (estimated)
- First submitted
- 29 Dec 2023
- Start date
- 9 Sept 2024
- Primary completion date
- 9 May 2027
- Lead sponsor
- University Hospital, Rouen
- Diseases
- Lung cancer
- NCT number
- NCT06202222
What you commit to
- Study type: Interventional
- Planned participants: 184
- From 9 Sept 2024 to the primary completion date, 9 May 2027
- 3 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- \- Contraindications to cyclo-ergometry: Deep vein thrombosis in a lower limb. Patients with one or both lower limbs amputated. Rheumatological pathology, trauma, or previous surgery in the lower limb, pelvis, or spine, resulting in limited joint amplitude or strict immobilization.
- Patients who have not undergone pulmonary resection by minimally invasive surgery.
- Patients hospitalized outside the thoracic surgery department before the first post-operative visit with the physiotherapist on Day 0.
Other illness
- Dermatological conditions with severe lesions preventing prolonged sitting on a bicycle.
Other
- Glasgow score less than 15.
Who the study is looking for
- Patients requiring surgery for diagnosed or undergoing diagnosis of lung cancer.
- Patients in need of major lung resection through a minimally invasive approach.
- Patients capable of performing the chair rise test.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (3)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Caen University Hospital Coordinator of this site? Confirm its status | Caen | France | Recruiting |
| Rouen University Hospital Coordinator of this site? Confirm its status | Rouen | France | Recruiting |
| Valenciennes, Hospital Coordinator of this site? Confirm its status | Valenciennes | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.